McKinsey pitched Purdue Pharma Canada on plan to boost opioid sales in 2014, memo reveals
Global consulting giant McKinsey & Co., under the leadership of Dominic Barton, pitched Purdue Pharma (Canada) in 2014 on how it could more aggressively market and boost sales of OxyContin and other highly addictive opioids to Canadians, according to a confidential memo obtained by The Globe and Mail.
McKinsey & Co. is facing a class-action lawsuit from the B.C. government, which Ottawa plans to join, that accuses the firm of engaging in reckless marketing campaigns to boost opioid sales, placing the Liberal government at odds with a company it has relied on for more than $100-million in contract work since 2015.
Barton is the same sociopath behind Trudeau’s mass immigration scam, he was a founding member of Century 100 and is also a China Class 5th columinist.
